BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1960 related articles for article (PubMed ID: 26151244)

  • 1. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Atopic Dermatitis From the Perspective of Traditional Persian Medicine: Presentation of a Novel Therapeutic Approach.
    Choopani R; Mehrbani M; Fekri A; Mehrabani M
    J Evid Based Complementary Altern Med; 2017 Jan; 22(1):5-11. PubMed ID: 26260045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
    de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
    Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of a cream containing AR-GG27® (sorbityl furfural palmitate) in the treatment of mild/moderate childhood atopic dermatitis associated with pityriasis alba. A double-blind, placebo-controlled clinical trial.
    Patrizi A; Raone B; Raboni R; Neri I
    G Ital Dermatol Venereol; 2012 Dec; 147(6 Suppl 1):1-8. PubMed ID: 23007324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.
    Silverberg JI; Adam DN; Zirwas M; Kalia S; Gutermuth J; Pinter A; Pink AE; Chiricozzi A; Barbarot S; Mark T; Tindberg AM; Weidinger S
    Am J Clin Dermatol; 2022 Jul; 23(4):547-559. PubMed ID: 35857179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new topical treatment of atopic dermatitis in pediatric patients based on Ficus carica L. (Fig): A randomized, placebo-controlled clinical trial.
    Abbasi S; Kamalinejad M; Babaie D; Shams S; Sadr Z; Gheysari M; Askari VR; Rakhshandeh H
    Complement Ther Med; 2017 Dec; 35():85-91. PubMed ID: 29154073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial.
    Guttman-Yassky E; Blauvelt A; Eichenfield LF; Paller AS; Armstrong AW; Drew J; Gopalan R; Simpson EL
    JAMA Dermatol; 2020 Apr; 156(4):411-420. PubMed ID: 32101256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
    Beck LA; Thaçi D; Hamilton JD; Graham NM; Bieber T; Rocklin R; Ming JE; Ren H; Kao R; Simpson E; Ardeleanu M; Weinstein SP; Pirozzi G; Guttman-Yassky E; Suárez-Fariñas M; Hager MD; Stahl N; Yancopoulos GD; Radin AR
    N Engl J Med; 2014 Jul; 371(2):130-9. PubMed ID: 25006719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
    Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
    Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
    Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
    Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
    Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
    Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypodium leucotomos extract in atopic dermatitis: a randomized, double-blind, placebo-controlled, multicenter trial.
    Ramírez-Bosca A; Zapater P; Betlloch I; Albero F; Martínez A; Díaz-Alperi J; Horga JF;
    Actas Dermosifiliogr; 2012 Sep; 103(7):599-607. PubMed ID: 22560125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
    Paller AS; Bansal A; Simpson EL; Boguniewicz M; Blauvelt A; Siegfried EC; Guttman-Yassky E; Hultsch T; Chen Z; Mina-Osorio P; Lu Y; Rossi AB; He X; Kamal M; Graham NMH; Pirozzi G; Ruddy M; Eckert L; Gadkari A
    Am J Clin Dermatol; 2020 Feb; 21(1):119-131. PubMed ID: 31823222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal medicine granules (PTQX) for children with moderate to severe atopic eczema: study protocol for a randomised controlled trial.
    Gu SX; Zhang AL; Coyle ME; Mo X; Lenon GB; Cranswick NE; Chen D; Xue CC
    Trials; 2015 Jul; 16():294. PubMed ID: 26149448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectoine-containing cream in the treatment of mild to moderate atopic dermatitis: a randomised, comparator-controlled, intra-individual double-blind, multi-center trial.
    Marini A; Reinelt K; Krutmann J; Bilstein A
    Skin Pharmacol Physiol; 2014; 27(2):57-65. PubMed ID: 23949258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial.
    Tsianakas A; Luger TA; Radin A
    Br J Dermatol; 2018 Feb; 178(2):406-414. PubMed ID: 28845523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 98.